Evaluation of PK and Safety of D-0120 and Allopurinol

A Phase I, Randomized, Open-label Study to Evaluate the Potential Pharmacokinetic Interactions Between D-0120 and Allopurinol in Healthy Adult Subjects

Evaluation of safety and PK interaction between D-0120 and Alopurinol in healthy adult subjects

Inclusion Criteria:

• Healthy subjects between the ages of 18-55
• Required evaluation by Investigator for screening and enrollment
• Agreement and compliance with the study and follow-up procedures

Exclusion Criteria:

• Significant medical history or current comorbidly determined by the Investigator.
• Pregnant or nursing women